Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,188,875 | -733,339 | 1,283,716 | 13,648,440 | 17,801,400 |
| Depreciation Amortization | 433,100 | 322,466 | 198,494 | 129,909 | 88,969 |
| Accounts receivable | 1,226,098 | 419,530 | 5,816,280 | 4,604,126 | -13,970,160 |
| Accounts payable and accrued liabilities | -818,907 | 820,665 | 128,686 | 90,294 | 1,793,698 |
| Other Working Capital | 608,467 | 1,320,811 | 6,033,606 | 4,760,691 | -12,695,140 |
| Other Operating Activity | 256,036 | -1,925,380 | -7,647,315 | -8,928,309 | 8,033,837 |
| Operating Cash Flow | $515,918 | $224,752 | $5,813,466 | $14,305,150 | $1,052,604 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -443,899 |
| PPE Investments | -193,017 | -308,723 | -270,683 | -346,213 | -146,823 |
| Net Acquisitions | 210,780 | N/A | -364,627 | N/A | -24,609 |
| Purchase Of Investment | -12,923,420 | -13,385,900 | -7,715,067 | -50,362 | -23,071 |
| Sale Of Investment | 10,762,100 | 11,621,970 | 1,316,401 | 395,311 | N/A |
| Purchase Sale Intangibles | -649,311 | -179,412 | -492,879 | -35,928 | -31,352 |
| Other Investing Activity | -649,304 | -179,413 | -492,879 | -35,928 | -31,352 |
| Investing Cash Flow | $-2,792,861 | $-2,252,066 | $-7,526,855 | $-37,192 | $-669,753 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,580 | N/A | 325 | 843 | N/A |
| Debt Repayment | -20,365 | -2,489 | -108 | -19,808 | -62,231 |
| Common Stock Issued | N/A | N/A | N/A | 116,423 | 190,361 |
| Common Stock Repurchased | N/A | N/A | -799,279 | -1,039,271 | N/A |
| Dividend Paid | N/A | N/A | N/A | -510,259 | N/A |
| Other Financing Activity | -47,066 | -47,180 | -43,617 | -43,304 | -16,682 |
| Financing Cash Flow | $-59,851 | $-49,668 | $-842,679 | $-1,495,375 | $111,448 |
| Exchange Rate Effect | -30,548 | 16,015 | -15,693 | 62,795 | 76,547 |
| Beginning Cash Position | 11,044,610 | 12,621,290 | 15,017,020 | 1,783,429 | 1,431,788 |
| End Cash Position | 8,683,947 | 10,563,350 | 12,623,620 | 14,618,810 | 2,002,633 |
| Net Cash Flow | $-2,360,666 | $-2,057,938 | $-2,393,398 | $12,835,380 | $570,846 |
| Free Cash Flow | |||||
| Operating Cash Flow | 515,918 | 224,752 | 5,813,466 | 14,305,150 | 1,052,604 |
| Capital Expenditure | -198,108 | -310,022 | -269,926 | -346,845 | -150,845 |
| Free Cash Flow | 317,810 | -85,269 | 5,543,540 | 13,958,305 | 901,759 |